Nutritional aspects and food management in the control of Polycystic Ovarian Syndrome
DOI:
https://doi.org/10.33448/rsd-v11i9.31526Keywords:
Polycystic Ovarian Syndrome; Insulin resistance; Diet and dietary supplements.Abstract
To evaluate the nutritional aspects and nutritional management in Polycystic Ovary Syndrome (PCOS), describing its pathology, clinical manifestations, diagnosis, treatment and nutritional approach in Polycystic Ovary Syndrome. This is a non-systematic literature review study with articles associated with the Polycystic Ovary Syndrome (PCOS) theme, from the scientific databases Pubmed, Scielo, Tripdatabase and Google Scholar. The practice of physical exercises associated with a change in lifestyle (diet) and follow-up with a gynecologist has been considered a beneficial advance for the control of symptoms in women with PCOS. In this way, it is concluded that a hypocaloric diet is indicated, with foods with a low glycemic index, since they can act positively in the PCOS framework. Finally, some supplements such as omega 3, inositol, n - acetylcysteine and vitamin D can help in the control and symptoms of PCOS.
References
Arduc, A., Aycicek Dogan, B., Bilmez, S., Imga Nasiroglu, N., Tuna, M. M., Isik, S., ... & Guler, S. (2015). High prevalence of Hashimoto’s thyroiditis in patients with polycystic ovary syndrome: does the imbalance between estradiol and progesterone play a role?. Endocrine research, 40(4), 204-210. DOI: 10.3109/07435800.2015.1015730 https://pubmed.ncbi.nlm.nih.gov/25822940/
Akdoğan, M., Tamer, M. N., Cüre, E., Cüre, M. C., Köroğlu, B. K., & Delibaş, N. (2007). Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 21(5), 444-447.
Campos, A. E., Leão, M. E. B., & de Souza, M. A. (2021). O impacto da mudança do estilo de vida em mulheres com síndrome dos ovários policísticos. Revista Eletrônica Acervo Saúde, 13(2), e4354-e4354. DOI: https://doi.org/10.25248/reas.e4354.2021 https://acervomais.com.br/index.php/saude/article/view/4354/3277
Chan, C. C., Koo, M. W., Ng, E. H., Tang, O. S., Yeung, W. S., & Ho, P. C. (2006). Effects of Chinese green tea on weight and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome—a randomized placebo-controlled trial. The Journal of the Society for Gynecologic Investigation: JSGI, 13(1), 63-68. DOI: 10.1016/j.jsgi.2005.10.006 https://pubmed.ncbi.nlm.nih.gov/16378915/
Cahill, D. J. (2009). Pcos. BMJ clinical evidence, 2009. PMID: 25814168 https://pubmed.ncbi.nlm.nih.gov/19445767/
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015). Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocrine reviews, 36(5), 487-525. DOI: https://doi.org/10.1210/er.2015-1018 https://academic.oup.com/edrv/article/36/5/487/2354671
Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270-284. DOI: 10.1038/nrendo.2018.24 https://pubmed.ncbi.nlm.nih.gov/29569621/
Farshchi, H., Rane, A., Love, A., & Kennedy, R. L. (2007). Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management. Journal of obstetrics and gynaecology, 27(8), 762-773. DOI: 10.1080/01443610701667338 https://pubmed.ncbi.nlm.nih.gov/18097891/
Günalan, E., Yaba, A., & Yılmaz, B. (2018). The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review. Journal of the Turkish German Gynecological Association, 19(4), 220. DOI: 10.4274/jtgga.2018.0077 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250088/pdf/JTGGA-19-220.pdf
Izadi, A., Ebrahimi, S., Shirazi, S., Taghizadeh, S., Parizad, M., Farzadi, L., & Gargari, B. P. (2019). Hormonal and metabolic effects of coenzyme Q10 and/or vitamin E in patients with polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 104(2), 319-327. DOI: 10.1210/jc.2018-01221 https://pubmed.ncbi.nlm.nih.gov/30202998/
Javanmanesh, F., Kashanian, M., Rahimi, M., & Sheikhansari, N. (2016). A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome. Gynecological Endocrinology, 32(4), 285-289. DOI: 10.3109/09513590.2015.1115974 https://pubmed.ncbi.nlm.nih.gov/26654154/
Karakas, S. E. (2017). New biomarkers for diagnosis and management of polycystic ovary syndrome. Clinica Chimica Acta, 471, 248-253. DOI: 10.1016/j.cca.2017.06.009 https://pubmed.ncbi.nlm.nih.gov/28624501/
Lin, A. W., Kazemi, M., Jarrett, B. Y., Vanden Brink, H., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2019). Dietary and physical activity behaviors in women with polycystic ovary syndrome per the new international evidence-based guideline. Nutrients, 11(11), 2711. DOI: 10.3390/nu11112711 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893689/
Macedo, L. C., & ANTUNES, M. D. (2014). Marcadores moleculares e bioquímicos para a síndrome dos ovários policísticos. SaBios-Revista de Saúde e Biologia, 9(3), 118-131.ISSN:1980-0002 https://revista2.grupointegrado.br/revista/index.php/sabios/article/view/1713
Moran, L. J., Tassone, E. C., Boyle, J., Brennan, L., Harrison, C. L., Hirschberg, A. L., ... & Teede, H. J. (2020). Evidence summaries and recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management. Obesity Reviews, 21(10), e13046. DOI: https://doi.org/10.1111/obr.13046 https://onlinelibrary.wiley.com/doi/full/10.1111/obr.13046
Mousavi, R., Alizadeh, M., Asghari Jafarabadi, M., Heidari, L., Nikbakht, R., Babaahmadi Rezaei, H., & Karandish, M. (2022). Effects of melatonin and/or magnesium supplementation on biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Biological Trace Element Research, 200(3), 1010-1019. DOI: 10.1007/s12011-021-02725-y https://pubmed.ncbi.nlm.nih.gov/34009514/
Mu, Y., Cheng, D., Yin, T. L., & Yang, J. (2021). Vitamin D and polycystic ovary syndrome: a narrative review. Reproductive Sciences, 28(8), 2110-2117. DOI: 10.1007/s43032-020-00369-2 https://pubmed.ncbi.nlm.nih.gov/33113105/
Nasri, K., Jamilian, M., Rahmani, E., Bahmani, F., Tajabadi-Ebrahimi, M., & Asemi, Z. (2018). The effects of synbiotic supplementation on hormonal status, biomarkers of inflammation and oxidative stress in subjects with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. BMC Endocrine Disorders, 18(1), 1-8. DOI: 10.1186/s12902-018-0248-0 https://pubmed.ncbi.nlm.nih.gov/29649996/
Nestler, J. E. (2008). Metformin for the treatment of the polycystic ovary syndrome. New England Journal of Medicine, 358(1), 47-54. DOI: 10.1056/NEJMct0707092 https://pubmed.ncbi.nlm.nih.gov/18172174/
Pontes, A. G., Rehme, M. F. B., Martins, A. M. V. D. C., Micussi, M. T. A. B. C., Maranhão, T. M. D. O., Pimenta, W. D. P., & Pontes, A. (2012). Resistência à insulina em mulheres com síndrome dos ovários policísticos: relação com as variáveis antropométricas e bioquímicas. Revista Brasileira de Ginecologia e Obstetrícia, 34, 74-79. DOI: 10.1590/S0100-72032012000200006 www.scielo.br/j/rbgo/a/Nnk3tWHsrbcR6kVWmkf5yyN/abstract/?lang=pt
Rosa e Silva AC. Conceito, epidemiologia e fisiopatologia aplicada à prática clínica. In: Síndrome dos ovários policísticos. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia (Febrasgo); 2018. Cap. 1. p. 1-15. (Série Orientações e Recomendações Febrasgo, nº 4, Comissão Nacional de Ginecologia Endócrina). ISBN 978-85-94091-05-5. https://www.febrasgo.org.br/media/k2/attachments/Vol.Z47ZnZ9Z-Z2019.pdf
Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine reviews, 37(5), 467-520. DOI: 10.1210/er.2015-1104 https://pubmed.ncbi.nlm.nih.gov/27459230/
Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Molecular metabolism, 35, 100937. DOI: 10.1016/j.molmet.2020.01.001 https://pubmed.ncbi.nlm.nih.gov/32244180/
Senger, A. E. V., Schwanke, C. H., & Gottlieb, M. G. V. (2010). Chá verde (Camellia sinensis) e suas propriedades funcionais nas doenças crônicas não transmissíveis. Scientia Medica, 20(4), 292-300. https://revistaseletronicas.pucrs.br/ojs/index.php/scientiamedica/article/view/7051/
Silva, A. R. D. A., Dela-Sávia, V. S., Guimarães, N. S., & Zocateli, G. A. D. F. F. (2019). Efeitos da suplementação de ômega 3 na resistência à insulina em mulheres com síndrome do ovário policístico: revisão sistemática. HU rev, 195-202. DOI: 10.34019/1982-8047.2019.v45.26405 https://periodicos.ufjf.br/index.php/hurevista/article/view/26405/19673
de Sousa Xavier, E. C., & de Oliveira Freitas, F. M. N. (2021). Manejo dietético e suplementar na fisiopatologia da síndrome dos ovários policísticos. Research, Society and Development, 10(15), e237101522975-e237101522975. DOI: https://doi.org/10.33448/rsd-v10i15.22975 https://rsdjournal.org/index.php/rsd/article/view/22975
de Souza Pena, V., Gonçalves, A. C. R., Vieira, I. R., de Sousa, M. R., de Souza, A. C. D., La Croix, L. M. D. O., ... & da Cunha Gonçalves, S. J. (2022). Uma análise sobre as características da síndrome dos ovários policísticos: uma revisão de literatura. Revista Eletrônica Acervo Médico, 4, e9996-e9996. DOI: https://doi.org/10.25248/reamed.e9996.2022 https://acervomais.com.br/index.php/medico/article/view/9996
Spritzer, P. M., Lecke, S. B., Fabris, V. C., Ziegelmann, P. K., & Amaral, L. (2017). Blood trace element concentrations in polycystic ovary syndrome: systematic review and meta-analysis. Biological trace element research, 175(2), 254-262. DOI: 10.1007/s12011-016-0774-4 https://pubmed.ncbi.nlm.nih.gov/27301656/
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical endocrinology, 77(3), 343-350. DOI: 10.1111/j.1365-2265.2012.04434.x https://pubmed.ncbi.nlm.nih.gov/22574874/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Camila Melo Araújo de Moura e Lima ; Karina Cristina Gonçalves Pinto; Vanessa Maria Freire Correia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
